Cryoport, Inc. (CYRX)

US — Industrials Sector
Peers: BLFS  CDNA  AXNX  NTRA  IRTC 

Automate Your Wheel Strategy on CYRX

With Tiblio's Option Bot, you can configure your own wheel strategy including CYRX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CYRX
  • Rev/Share 4.3012
  • Book/Share 7.9847
  • PB 0.6763
  • Debt/Equity 0.6085
  • CurrentRatio 5.5555
  • ROIC -0.0877

 

  • MktCap 270740880.0
  • FreeCF/Share -0.5199
  • PFCF -10.4263
  • PE -2.4555
  • Debt/Assets 0.3467
  • DivYield 0
  • ROE -0.2713

 

  • Rating B-
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 4
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade CYRX UBS Neutral Buy -- $10 March 24, 2025
Initiation CYRX Guggenheim -- Buy -- $11 Dec. 19, 2024

News

Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade
CYRX
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive

The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Read More
image for news Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?
CYRX
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive

The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Read More
image for news Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect?
Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript
CYRX
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral

Cryoport, Inc. (NASDAQ:CYRX ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Kyle Crews - UBS Richard Baldry - ROTH Capital David Larsen - BTIG Subbu Nambi - Guggenheim Securities Matt Stanton - Jefferies Anna Snopkowski - KeyBanc Operator Good afternoon, and welcome to Cryoport's First Quarter 2025 Earnings Call. All participants will start in a listen-only mode.

Read More
image for news Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CYRX
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.43 per share a year ago.

Read More
image for news CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
CYRX
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive

CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read More
image for news CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
CYRX
Published: March 31, 2025 by: PRNewsWire
Sentiment: Neutral

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in specialty pharma logistics and supports Group's 2030 strategy to become a leader in life science and healthcare logistics.

Read More
image for news DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript
CYRX
Published: March 04, 2025 by: Seeking Alpha
Sentiment: Neutral

Start Time: 17:00 January 1, 0000 5:41 PM ET Cryoport, Inc. (NASDAQ:CYRX ) Q4 2024 Earnings Conference Call March 04, 2025, 17:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Anna Snopkowski - KeyBanc Capital Markets Puneet Souda - Leerink Partners David Saxon - Needham Subbu Nambi - Guggenheim David Larson - BTIG Richard Baldry - Roth Capital Kyle Crews - UBS Matt Stanton - Jefferies Operator Good afternoon, and welcome to …

Read More
image for news Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
CYRX
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Negative

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.51 per share a year ago.

Read More
image for news CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates

About Cryoport, Inc. (CYRX)

  • IPO Date 2005-08-22
  • Website https://www.cryoport.com
  • Industry Integrated Freight & Logistics
  • CEO Mr. Jerrell W. Shelton
  • Employees 1090

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.